A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD3.79
- USD3.90
- USD3.79
- USD4.73
- -16.90%
- 10M
- 443.79k
- 1.27M
- 725M
- 1.69
- 95.90%
Stock News
3 hours ago
End-of-life decisions can be impossibly hard. But the right senior-care team can make things a little easier.
MarketWatch
5 hours ago
Oil-Dri Of America (ODC) Q4 2024 Earnings Call Transcript
Yahoo
5 hours ago
We're raising our price target on Honeywell and adding another stock to the Bullpen
CNBC
6 hours ago
Tesla suffers $74bn hit after unveiling car with no steering wheel
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
